Your browser doesn't support javascript.
loading
Safety of Prasugrel in Indian patients - multicentric registry of 1000 cases.
Kaul, Upendra; Sethi, Arvind; Arambam, P; Omar, A K; Keshava, R; Roy, Sanjeeb; Ray, Shuvanan; Jaswal, Rakesh; Gupta, Ripan K; Sapra, Rakesh Rai; Keshav, Rane Sandip; Singh, Rajpal; Bhatia, Vineet; Sanghi, Vinay; Chopra, Arun.
Afiliação
  • Kaul U; Executive Director and Dean, Cardiology, Fortis Escorts Heart Institute, New Delhi, India. Electronic address: upendra.kaul@fortishealthcare.com.
  • Sethi A; Associate Consultant, Interventional Cardiology, Fortis Escorts Heart Institute, New Delhi, India.
  • Arambam P; Chief Clinical Research Coordinator, Fortis Escorts Heart Institute, New Delhi, India.
  • Omar AK; Director, Non Invasive Cardiology & Head of Department Heart Command & Emergency, Fortis Escorts Heart Institute, New Delhi, India.
  • Keshava R; Senior Consultant, Department of Cardiology, Fortis Hospital, Bangalore, India.
  • Roy S; Senior Consultant, Department of Cardiology, Fortis Escorts Hospital, Jaipur, India.
  • Ray S; Chief, Cardiology Intervention, Fortis Hospital, Kolkata, India.
  • Jaswal R; Director, Department of Cardiology, Fortis Hospital, Mohali, India.
  • Gupta RK; Principal Consultant, Fortis Hospital, Vasant Kunj, New Delhi, India.
  • Sapra RR; Senior Consultant & Head of Interventional Cardiology, Fortis Escorts Hospital, Faridabad, India.
  • Keshav RS; Director, Department of Cardiology, Fortis Hospital, Navi Mumbai, India.
  • Singh R; Interventional Cardiologist, Fortis Hospital, Bangalore, India.
  • Bhatia V; Consultant, Department of Cardiology, Fortis Hospital, Noida, India.
  • Sanghi V; Associate Director, Department of Cardiology, Fortis Hospital, Shalimar Bagh, Delhi, India.
  • Chopra A; Director, Department of Cardiology, Fortis Hospital, Amritsar, India.
Indian Heart J ; 66(6): 598-601, 2014.
Article em En | MEDLINE | ID: mdl-25634391

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Síndrome Coronariana Aguda / Intervenção Coronária Percutânea / Cloridrato de Prasugrel Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Síndrome Coronariana Aguda / Intervenção Coronária Percutânea / Cloridrato de Prasugrel Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2014 Tipo de documento: Article